Project Details
| Short title | BIG 19-02 |
|---|---|
| Acronym | Decrescendo |
| Status | Active |
| Effective start/end date | 1/09/22 → 9/06/27 |
CTU: De-escalation of adjuvant chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer subjects who achieved pathological complete response after neoadjuvant chemotherapy and dual HER2-blockade
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research